The global Androgen Antagonist market was valued at US$ 6650 million in 2023 and is anticipated to reach US$ 9984.3 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.

Androgen Antagonist Market

An androgen antagonist is a drug that blocks the effects of androgens, such as testosterone and dihydrotestosterone (DHT). Androgens are male sex hormones that play a role in many bodily functions, including sexual development, muscle growth, and bone density.

Androgen antagonists are also known as antiandrogens. They work by blocking androgens from binding to androgen receptors in cells. This prevents androgens from exerting their effects on those cells.

The growth of the market is attributed to the increasing prevalence of prostate cancer, the rising demand for effective treatments for prostate cancer, and the growing awareness of the benefits of androgen antagonist therapy.

Increasing prevalence of prostate cancer

Rising demand for effective treatments for prostate cancer

Growing awareness of the benefits of androgen antagonist therapy

Increasing government investments in cancer research and development

Technological advancements in androgen antagonist drug discovery and development

The androgen antagonist market is expected to continue to grow in the coming years, driven by the factors mentioned above.

This report aims to provide a comprehensive presentation of the global market for Androgen Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgen Antagonist.

Report Scope

The Androgen Antagonist market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Androgen Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Androgen Antagonist companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Androgen Antagonist Market Report

Report Metric	Details
Report Name	Androgen Antagonist Market
Accounted market size in 2023	US$ 6650 million
Forecasted market size in 2030	US$ 9984.3 million
CAGR	5.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Steroidal Androgen Antagonist Nonsteroidal Androgen Antagonist
Segment by Application	Prostate Cancer Benign Prostatic Hyperplasia Polycystic Ovary Syndrome (POCS) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui, Bayer, Schering-Plough, Hinova Pharma, Jiangsu Hengrui Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Androgen Antagonist companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Androgen Antagonist Market growing?

Ans: The Androgen Antagonist Market witnessing a CAGR of 5.6% during the forecast period 2024-2030.

What is the Androgen Antagonist Market size in 2030?

Ans: The Androgen Antagonist Market size in 2030 will be US$ 9984.3 million.

Who are the main players in the Androgen Antagonist Market report?

Ans: The main players in the Androgen Antagonist Market are Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui, Bayer, Schering-Plough, Hinova Pharma, Jiangsu Hengrui Pharmaceuticals

What are the Application segmentation covered in the Androgen Antagonist Market report?

Ans: The Applications covered in the Androgen Antagonist Market report are Prostate Cancer, Benign Prostatic Hyperplasia, Polycystic Ovary Syndrome (POCS), Others

What are the Type segmentation covered in the Androgen Antagonist Market report?

Ans: The Types covered in the Androgen Antagonist Market report are Steroidal Androgen Antagonist, Nonsteroidal Androgen Antagonist

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Androgen Antagonist Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Steroidal Androgen Antagonist

1.2.3 Nonsteroidal Androgen Antagonist

1.3 Market by Application

1.3.1 Global Androgen Antagonist Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Prostate Cancer

1.3.3 Benign Prostatic Hyperplasia

1.3.4 Polycystic Ovary Syndrome (POCS)

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Androgen Antagonist Market Perspective (2019-2030)

2.2 Androgen Antagonist Growth Trends by Region

2.2.1 Global Androgen Antagonist Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Androgen Antagonist Historic Market Size by Region (2019-2024)

2.2.3 Androgen Antagonist Forecasted Market Size by Region (2025-2030)

2.3 Androgen Antagonist Market Dynamics

2.3.1 Androgen Antagonist Industry Trends

2.3.2 Androgen Antagonist Market Drivers

2.3.3 Androgen Antagonist Market Challenges

2.3.4 Androgen Antagonist Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Androgen Antagonist Players by Revenue

3.1.1 Global Top Androgen Antagonist Players by Revenue (2019-2024)

3.1.2 Global Androgen Antagonist Revenue Market Share by Players (2019-2024)

3.2 Global Androgen Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Androgen Antagonist Revenue

3.4 Global Androgen Antagonist Market Concentration Ratio

3.4.1 Global Androgen Antagonist Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Androgen Antagonist Revenue in 2023

3.5 Androgen Antagonist Key Players Head office and Area Served

3.6 Key Players Androgen Antagonist Product Solution and Service

3.7 Date of Enter into Androgen Antagonist Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Androgen Antagonist Breakdown Data by Type

4.1 Global Androgen Antagonist Historic Market Size by Type (2019-2024)

4.2 Global Androgen Antagonist Forecasted Market Size by Type (2025-2030)

5 Androgen Antagonist Breakdown Data by Application

5.1 Global Androgen Antagonist Historic Market Size by Application (2019-2024)

5.2 Global Androgen Antagonist Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Androgen Antagonist Market Size (2019-2030)

6.2 North America Androgen Antagonist Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Androgen Antagonist Market Size by Country (2019-2024)

6.4 North America Androgen Antagonist Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Androgen Antagonist Market Size (2019-2030)

7.2 Europe Androgen Antagonist Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Androgen Antagonist Market Size by Country (2019-2024)

7.4 Europe Androgen Antagonist Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Androgen Antagonist Market Size (2019-2030)

8.2 Asia-Pacific Androgen Antagonist Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Androgen Antagonist Market Size by Region (2019-2024)

8.4 Asia-Pacific Androgen Antagonist Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Androgen Antagonist Market Size (2019-2030)

9.2 Latin America Androgen Antagonist Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Androgen Antagonist Market Size by Country (2019-2024)

9.4 Latin America Androgen Antagonist Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Androgen Antagonist Market Size (2019-2030)

10.2 Middle East & Africa Androgen Antagonist Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Androgen Antagonist Market Size by Country (2019-2024)

10.4 Middle East & Africa Androgen Antagonist Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Androgen Antagonist Introduction

11.1.4 Pfizer Revenue in Androgen Antagonist Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Androgen Antagonist Introduction

11.2.4 Johnson & Johnson Revenue in Androgen Antagonist Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Detail

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Androgen Antagonist Introduction

11.3.4 AstraZeneca Revenue in Androgen Antagonist Business (2019-2024)

11.3.5 AstraZeneca Recent Development

11.4 Astellas

11.4.1 Astellas Company Detail

11.4.2 Astellas Business Overview

11.4.3 Astellas Androgen Antagonist Introduction

11.4.4 Astellas Revenue in Androgen Antagonist Business (2019-2024)

11.4.5 Astellas Recent Development

11.5 Merck

11.5.1 Merck Company Detail

11.5.2 Merck Business Overview

11.5.3 Merck Androgen Antagonist Introduction

11.5.4 Merck Revenue in Androgen Antagonist Business (2019-2024)

11.5.5 Merck Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Detail

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Androgen Antagonist Introduction

11.6.4 Sanofi Revenue in Androgen Antagonist Business (2019-2024)

11.6.5 Sanofi Recent Development

11.7 Orion Corporation

11.7.1 Orion Corporation Company Detail

11.7.2 Orion Corporation Business Overview

11.7.3 Orion Corporation Androgen Antagonist Introduction

11.7.4 Orion Corporation Revenue in Androgen Antagonist Business (2019-2024)

11.7.5 Orion Corporation Recent Development

11.8 Hengrui

11.8.1 Hengrui Company Detail

11.8.2 Hengrui Business Overview

11.8.3 Hengrui Androgen Antagonist Introduction

11.8.4 Hengrui Revenue in Androgen Antagonist Business (2019-2024)

11.8.5 Hengrui Recent Development

11.9 Bayer

11.9.1 Bayer Company Detail

11.9.2 Bayer Business Overview

11.9.3 Bayer Androgen Antagonist Introduction

11.9.4 Bayer Revenue in Androgen Antagonist Business (2019-2024)

11.9.5 Bayer Recent Development

11.10 Schering-Plough

11.10.1 Schering-Plough Company Detail

11.10.2 Schering-Plough Business Overview

11.10.3 Schering-Plough Androgen Antagonist Introduction

11.10.4 Schering-Plough Revenue in Androgen Antagonist Business (2019-2024)

11.10.5 Schering-Plough Recent Development

11.11 Hinova Pharma

11.11.1 Hinova Pharma Company Detail

11.11.2 Hinova Pharma Business Overview

11.11.3 Hinova Pharma Androgen Antagonist Introduction

11.11.4 Hinova Pharma Revenue in Androgen Antagonist Business (2019-2024)

11.11.5 Hinova Pharma Recent Development

11.12 Jiangsu Hengrui Pharmaceuticals

11.12.1 Jiangsu Hengrui Pharmaceuticals Company Detail

11.12.2 Jiangsu Hengrui Pharmaceuticals Business Overview

11.12.3 Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Introduction

11.12.4 Jiangsu Hengrui Pharmaceuticals Revenue in Androgen Antagonist Business (2019-2024)

11.12.5 Jiangsu Hengrui Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Jiangsu Hengrui Pharmaceuticals

Astellas

List of Tables

Table 1. Global Androgen Antagonist Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Steroidal Androgen Antagonist

Table 3. Key Players of Nonsteroidal Androgen Antagonist

Table 4. Global Androgen Antagonist Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Androgen Antagonist Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Androgen Antagonist Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Androgen Antagonist Market Share by Region (2019-2024)

Table 8. Global Androgen Antagonist Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Androgen Antagonist Market Share by Region (2025-2030)

Table 10. Androgen Antagonist Market Trends

Table 11. Androgen Antagonist Market Drivers

Table 12. Androgen Antagonist Market Challenges

Table 13. Androgen Antagonist Market Restraints

Table 14. Global Androgen Antagonist Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Androgen Antagonist Market Share by Players (2019-2024)

Table 16. Global Top Androgen Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Antagonist as of 2023)

Table 17. Ranking of Global Top Androgen Antagonist Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Androgen Antagonist Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Androgen Antagonist Product Solution and Service

Table 21. Date of Enter into Androgen Antagonist Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Androgen Antagonist Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Androgen Antagonist Revenue Market Share by Type (2019-2024)

Table 25. Global Androgen Antagonist Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Androgen Antagonist Revenue Market Share by Type (2025-2030)

Table 27. Global Androgen Antagonist Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Androgen Antagonist Revenue Market Share by Application (2019-2024)

Table 29. Global Androgen Antagonist Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Androgen Antagonist Revenue Market Share by Application (2025-2030)

Table 31. North America Androgen Antagonist Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Androgen Antagonist Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Androgen Antagonist Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Androgen Antagonist Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Androgen Antagonist Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Androgen Antagonist Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Androgen Antagonist Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Androgen Antagonist Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Androgen Antagonist Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Androgen Antagonist Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Androgen Antagonist Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Androgen Antagonist Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Androgen Antagonist Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Androgen Antagonist Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Androgen Antagonist Market Size by Country (2025-2030) & (US$ Million)

Table 46. Pfizer Company Detail

Table 47. Pfizer Business Overview

Table 48. Pfizer Androgen Antagonist Product

Table 49. Pfizer Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. Johnson & Johnson Company Detail

Table 52. Johnson & Johnson Business Overview

Table 53. Johnson & Johnson Androgen Antagonist Product

Table 54. Johnson & Johnson Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 55. Johnson & Johnson Recent Development

Table 56. AstraZeneca Company Detail

Table 57. AstraZeneca Business Overview

Table 58. AstraZeneca Androgen Antagonist Product

Table 59. AstraZeneca Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 60. AstraZeneca Recent Development

Table 61. Astellas Company Detail

Table 62. Astellas Business Overview

Table 63. Astellas Androgen Antagonist Product

Table 64. Astellas Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 65. Astellas Recent Development

Table 66. Merck Company Detail

Table 67. Merck Business Overview

Table 68. Merck Androgen Antagonist Product

Table 69. Merck Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 70. Merck Recent Development

Table 71. Sanofi Company Detail

Table 72. Sanofi Business Overview

Table 73. Sanofi Androgen Antagonist Product

Table 74. Sanofi Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 75. Sanofi Recent Development

Table 76. Orion Corporation Company Detail

Table 77. Orion Corporation Business Overview

Table 78. Orion Corporation Androgen Antagonist Product

Table 79. Orion Corporation Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 80. Orion Corporation Recent Development

Table 81. Hengrui Company Detail

Table 82. Hengrui Business Overview

Table 83. Hengrui Androgen Antagonist Product

Table 84. Hengrui Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 85. Hengrui Recent Development

Table 86. Bayer Company Detail

Table 87. Bayer Business Overview

Table 88. Bayer Androgen Antagonist Product

Table 89. Bayer Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 90. Bayer Recent Development

Table 91. Schering-Plough Company Detail

Table 92. Schering-Plough Business Overview

Table 93. Schering-Plough Androgen Antagonist Product

Table 94. Schering-Plough Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 95. Schering-Plough Recent Development

Table 96. Hinova Pharma Company Detail

Table 97. Hinova Pharma Business Overview

Table 98. Hinova Pharma Androgen Antagonist Product

Table 99. Hinova Pharma Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 100. Hinova Pharma Recent Development

Table 101. Jiangsu Hengrui Pharmaceuticals Company Detail

Table 102. Jiangsu Hengrui Pharmaceuticals Business Overview

Table 103. Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Product

Table 104. Jiangsu Hengrui Pharmaceuticals Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 105. Jiangsu Hengrui Pharmaceuticals Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Androgen Antagonist Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Androgen Antagonist Market Share by Type: 2023 VS 2030

Figure 3. Steroidal Androgen Antagonist Features

Figure 4. Nonsteroidal Androgen Antagonist Features

Figure 5. Global Androgen Antagonist Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Androgen Antagonist Market Share by Application: 2023 VS 2030

Figure 7. Prostate Cancer Case Studies

Figure 8. Benign Prostatic Hyperplasia Case Studies

Figure 9. Polycystic Ovary Syndrome (POCS) Case Studies

Figure 10. Others Case Studies

Figure 11. Androgen Antagonist Report Years Considered

Figure 12. Global Androgen Antagonist Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Androgen Antagonist Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Androgen Antagonist Market Share by Region: 2023 VS 2030

Figure 15. Global Androgen Antagonist Market Share by Players in 2023

Figure 16. Global Top Androgen Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Antagonist as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Androgen Antagonist Revenue in 2023

Figure 18. North America Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Androgen Antagonist Market Share by Country (2019-2030)

Figure 20. United States Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Androgen Antagonist Market Share by Country (2019-2030)

Figure 24. Germany Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Androgen Antagonist Market Share by Region (2019-2030)

Figure 32. China Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Androgen Antagonist Market Share by Country (2019-2030)

Figure 40. Mexico Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Androgen Antagonist Market Share by Country (2019-2030)

Figure 44. Turkey Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Pfizer Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 47. Johnson & Johnson Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 48. AstraZeneca Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 49. Astellas Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 50. Merck Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 51. Sanofi Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 52. Orion Corporation Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 53. Hengrui Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 54. Bayer Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 55. Schering-Plough Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 56. Hinova Pharma Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 57. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Asset Management Software Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7H15710

Tue Aug 27 00:00:00 UTC 2024

Add to Cart

Global Drug Interactions Checker Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12A14387

Mon Aug 26 00:00:00 UTC 2024

Add to Cart

Global Elderly Care Service Certification Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0W16001

Wed Aug 21 00:00:00 UTC 2024

Add to Cart

Global Androgen Antagonist Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24N12667

Wed Aug 21 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions